
There has been little change in the formulation of bone cements since Sir John Charnley first developed them in the 1970s. Bone cements are methacrylate based systems packaged in two components [1]. The powder component contains a mixture of polymethyl methacrylate (PMMA), methyl methacrylate-styrene-copolymer, and a radio opacifier (either barium sulfate or zirconium oxide) [2]. The second component is a liquid monomer typically containing methyl methacrylate, N, N-dimethyl-p-toluidine (activator), and hydroquinone. Flexural strength and flexural modulus of bone cements range between 60–75 MPa and 2.2–3.3 GPa, respectively [3, 4]. ISO 5833 requires bone cements to have a strength greater than 50 MPa and a modulus greater than 1.8 GPa [5].
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
